218 related articles for article (PubMed ID: 23533274)
1. TPL2 kinase is a suppressor of lung carcinogenesis.
Gkirtzimanaki K; Gkouskou KK; Oleksiewicz U; Nikolaidis G; Vyrla D; Liontos M; Pelekanou V; Kanellis DC; Evangelou K; Stathopoulos EN; Field JK; Tsichlis PN; Gorgoulis V; Liloglou T; Eliopoulos AG
Proc Natl Acad Sci U S A; 2013 Apr; 110(16):E1470-9. PubMed ID: 23533274
[TBL] [Abstract][Full Text] [Related]
2. NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function.
Sun F; Qu Z; Xiao Y; Zhou J; Burns TF; Stabile LP; Siegfried JM; Xiao G
Oncogene; 2016 May; 35(18):2299-310. PubMed ID: 26300007
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
[TBL] [Abstract][Full Text] [Related]
4. Physical and functional interaction of the TPL2 kinase with nucleophosmin.
Kanellis DC; Bursac S; Tsichlis PN; Volarevic S; Eliopoulos AG
Oncogene; 2015 May; 34(19):2516-26. PubMed ID: 24998852
[TBL] [Abstract][Full Text] [Related]
5. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
[TBL] [Abstract][Full Text] [Related]
6. Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis.
Decicco-Skinner KL; Trovato EL; Simmons JK; Lepage PK; Wiest JS
Oncogene; 2011 Jan; 30(4):389-97. PubMed ID: 20935675
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of TPL2 in early‑stage non‑small cell lung cancer.
Boldrini L; Giordano M; Servadio A; Niccoli C; Bertoglio P; Lucchi M; Melfi F; Mussi A; Fontanini G
Mol Med Rep; 2017 Jun; 15(6):3451-3458. PubMed ID: 28393206
[TBL] [Abstract][Full Text] [Related]
8. Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity.
Njunge LW; Estania AP; Guo Y; Liu W; Yang L
Theranostics; 2020; 10(18):8343-8364. PubMed ID: 32724474
[TBL] [Abstract][Full Text] [Related]
9. Altered prostanoid signaling contributes to increased skin tumorigenesis in Tpl2 knockout mice.
DeCicco-Skinner KL; Nolan SJ; Deshpande MM; Trovato EL; Dempsey TA; Wiest JS
PLoS One; 2013; 8(2):e56212. PubMed ID: 23457529
[TBL] [Abstract][Full Text] [Related]
10. Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis.
Koliaraki V; Roulis M; Kollias G
J Clin Invest; 2012 Nov; 122(11):4231-42. PubMed ID: 23064365
[TBL] [Abstract][Full Text] [Related]
11. TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations.
Dodhiawala PB; Khurana N; Zhang D; Cheng Y; Li L; Wei Q; Seehra K; Jiang H; Grierson PM; Wang-Gillam A; Lim KH
J Clin Invest; 2020 Sep; 130(9):4771-4790. PubMed ID: 32573499
[TBL] [Abstract][Full Text] [Related]
12. Advancement in TPL2-regulated innate immune response.
Yan MH; Hao JH; Zhang XG; Shen CC; Zhang DJ; Zhang KS; Zheng HX; Liu XT
Immunobiology; 2019 May; 224(3):383-387. PubMed ID: 30853309
[TBL] [Abstract][Full Text] [Related]
13. A serine/threonine kinase, Cot/Tpl2, modulates bacterial DNA-induced IL-12 production and Th cell differentiation.
Sugimoto K; Ohata M; Miyoshi J; Ishizaki H; Tsuboi N; Masuda A; Yoshikai Y; Takamoto M; Sugane K; Matsuo S; Shimada Y; Matsuguchi T
J Clin Invest; 2004 Sep; 114(6):857-66. PubMed ID: 15372110
[TBL] [Abstract][Full Text] [Related]
14. Tpl2 is a key mediator of arsenite-induced signal transduction.
Lee KM; Lee KW; Bode AM; Lee HJ; Dong Z
Cancer Res; 2009 Oct; 69(20):8043-9. PubMed ID: 19808956
[TBL] [Abstract][Full Text] [Related]
15. Tumor progression locus 2 (Tpl2) kinase promotes chemokine receptor expression and macrophage migration during acute inflammation.
Rowley SM; Kuriakose T; Dockery LM; Tran-Nguyen T; Gingerich AD; Wei L; Watford WT
J Biol Chem; 2014 May; 289(22):15788-97. PubMed ID: 24713702
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of miR-144 after Mycobacterium tuberculosis infection promotes inflammatory factor secretion from macrophages through the Tpl2/ERK pathway.
Liu HY
Cell Mol Biol (Noisy-le-grand); 2016 Feb; 62(2):87-93. PubMed ID: 26950457
[TBL] [Abstract][Full Text] [Related]
17. The role of tumor progression locus 2 protein kinase in glial inflammatory response.
Hirschhorn J; Mohanty S; Bhat NR
J Neurochem; 2014 Mar; 128(6):919-26. PubMed ID: 24188160
[TBL] [Abstract][Full Text] [Related]
18. TPL2 kinase regulates the inflammatory milieu of the myeloma niche.
Hope C; Ollar SJ; Heninger E; Hebron E; Jensen JL; Kim J; Maroulakou I; Miyamoto S; Leith C; Yang DT; Callander N; Hematti P; Chesi M; Bergsagel PL; Asimakopoulos F
Blood; 2014 May; 123(21):3305-15. PubMed ID: 24723682
[TBL] [Abstract][Full Text] [Related]
19. Tumor Progression Locus 2 in Hepatocytes Potentiates Both Liver and Systemic Metabolic Disorders in Mice.
Gong J; Fang C; Zhang P; Wang PX; Qiu Y; Shen LJ; Zhang L; Zhu XY; Tian S; Li F; Wang Z; Huang Z; Wang A; Zhang XD; She ZG
Hepatology; 2019 Feb; 69(2):524-544. PubMed ID: 29381809
[TBL] [Abstract][Full Text] [Related]
20. Tumor Progression Locus 2 Promotes Induction of IFNλ, Interferon Stimulated Genes and Antigen-Specific CD8+ T Cell Responses and Protects against Influenza Virus.
Kuriakose T; Tripp RA; Watford WT
PLoS Pathog; 2015 Aug; 11(8):e1005038. PubMed ID: 26241898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
